Анналы клинических и лабораторных исследований

  • ISSN: 2386-5180
  • Индекс Хирша журнала: 17
  • Оценка цитируемости журнала: 6.26
  • Импакт-фактор журнала: 5.31
Индексировано в
  • Журнал GenamicsSeek
  • Китайская национальная инфраструктура знаний (CNKI)
  • CiteFactor
  • Справочник индексации исследовательских журналов (DRJI)
  • Паблоны
  • Евро Паб
  • Google Scholar
  • ШЕРПА РОМЕО
  • Секретные лаборатории поисковых систем
Поделиться этой страницей

Абстрактный

Impact of Fingolimod on Multiple Sclerosis

Mamatha Dereddy*

Fingolimod could be a sphingosine-1-phosphate receptor modulator that sequesters liquid body substanceocytes in lymph nodes preventing them from conducive to a reaction reaction. it's been reportable to scale back the speed of relapses in relapsing-remitting disseminated multiple sclerosis by or so common fraction over a biennial amount. Fingolimod was shown to be effective in experimental reaction rubor, six AN animal model of disseminated multiple sclerosis (MS), and later investigated in 2 clinical trial clinical trials for relapsingremitting (RR)MS. seven In these trials, fingolimod was incontestable to be a secure and effective drug.